P.E.I.'s Chief Public Health Officer is working towards expanding eligibility for RSV vaccines as the province experiences ...

More than 86,000 recorded cases of respiratory syncytial virus in 2024 were in children younger than four years old.

The Cyprus pulmonology society on Thursday urged Health Minister Michael Damianos to approve a respiratory syncytial virus ...

Vulnerable and elderly Australians are missing out on protection against respiratory syncytial virus (RSV) because many can’t ...

A new study is showing a policy change in 2016 related to the vaccination of some premature babies for RSV in Nova Scotia led ...

Over a third of women giving birth got the new RSV vaccine in September, protecting newborns from severe illness. The new maternal Respiratory ...

Sanofi’s jump in earnings comes with an increased emphasis on R&D and vaccines, plus an eye cast toward M&A to shore up its pipeline.

Among adults aged 75 and older, RSV was linked to a substantial burden of hospitalizations, ICU admissions, and in-hospital deaths before vaccines were available.

“But also in this instance (the RSV vaccine) would be beneficial for our older patients because it would enable a reduction in the RSV cases,” Dr Raman said. “There’s a lot of expenses and ...

The policy was reversed in 2023, when a new RSV vaccine for infants was introduced. Halifax pediatric infectious disease physician Joanne Langley said the study shows why it's crucial to examine the ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

The study, published Jan. 20 in The Lancet Infectious Diseases, found the vaccine to be 78% effective against RSV infection, 79% effective against emergency department and urgent care visits and 80% ...